Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > Email from TST management - November 19
View:
Post by cndexpatman on Nov 25, 2015 1:37am

Email from TST management - November 19

Well at least they responded, even if it's a boiler plate repsonse.

Agreed that the next "PR" and communication from management will dictate how February will likely go down.

-----------------------------------------
Dear XXXX,
Thanks for writing. As you can imagine, we are receiving a lot of queries from shareholders on the meaning of the outcome of the AdComm.
As Telesta is a public listed company, I can only share with you information that is in the public domain.
In terms of general comments:
  • While we are disappointed in the results of the Advisory Committee, their views are just one of the elements that the FDA takes into consideration in their approval decision.
  • All but one of the practicing urologists on the panel voted Yes.
  • Our PDUFA date remains February 27, 2015
  • Telesta's management team, professional advisors and partners will be working very hard and diligently over the next 3 months to maximize our potential for a positive FDA decision.
Best regards,
Don
Donald Olds, M.Sc., MBA
Chief Operating Officer
Chef de l’exploitation
Telesta Therapeutics Inc.


275 avenue Labrosse
Pointe-Claire, QC
H9R 1A3
T: 514.394.7921







From: XXXX
Date: Thursday, November 19, 2015 at 11:50 AM
To: Don Olds <donald.olds@telestatherapeutics.com>
Subject: FDA Advisory Committee Vote
Hello Donald,
As a long time shareholder I have not reached out in the past however I am curious to know what your management team is planning in terms of ensuring, that despite the negative outcome yesterday, the potential approval by the FDA in early 2016 is given the maximum chance of success. I realize the precedent of a no vote by the FDA Advisory Committee doesn’t bode well traditionally in getting FDA approval.
Any information or insights you can share with me when your schedule allows would be appreciated.
Regards,
XXXX
Comment by barneyj44 on Nov 25, 2015 2:00am
Thanks for sharing 
Comment by ragingbull1327 on Nov 25, 2015 7:31am
Why would shareholders be inundating Donald Olds?    Wtf is wrong with you people?   You're ACTUALLY nervous of the outcome???   Wtf man.   If this is all true, and people are really this confused, then our species is phuccccking beat
Comment by ragingbull1327 on Nov 25, 2015 7:48am
Worst Case Scenario: decision is no..... ME:   I lose some OPM.   Lots of OPM FDA:    Look like incompetent retards, who fail people tbeir risk is way higher.   They have much more on the line.....
Comment by ragingbull1327 on Nov 25, 2015 7:55am
In fact, the worst I can do is simply shift my OPM into some other poor b-tards hands.  lol
Comment by txbioinv on Nov 25, 2015 5:06pm
STFU..........mind your own faaacking business rgbullschiiit. We all as shareholders own a piece of the action........................so please stfu.
Comment by ragingbull1327 on Nov 25, 2015 7:58am
How can they be DISAPPOINTED???   The decision and meeting were meaningless.   I wouldn't care EITHER WAY about meaningless.   I'd tell them it was meaningless when I left the meeting with them, and I'd tell them if they don't have an answer already and have to run THIS ADCOMM TV SHOW within 3 months of PDUFA, that it best be a yes or they should have shut this for ...more  
Comment by ragingbull1327 on Nov 25, 2015 8:02am
When this is all over, I'm def writing a book about this.     lol
Comment by DamnYankees on Nov 25, 2015 8:07am
Translation, let us get our 10 million options at 18 cent out of the way at Xmas and we'll update you in mid January. 
Comment by thathurt on Nov 25, 2015 8:19am
expat, seems you got the very professional brush off (i could say you were told to go f yourself but won't)..to bad we didn't have a more professional AdCom with Olds there handing out strong messages then..in which case you wouldn't have had to email as you did.. ...ps while Olds can only respond in certain ways, again to criticize failed messaging by TST during this crisis, i note ...more  
Comment by DamnYankees on Nov 25, 2015 8:41am
Hurt,Options  - millions of them. What is another 5 or 6 weeks of rampant uncertainty  for retailers in the big scheme of things. Words have a way of comforting people so focus on the word "Options" and think millions of them. As many have stated previously, this management team should be rewarded for getting us to where they have. "Options" .  Besides if the ...more  
Comment by DamnYankees on Nov 25, 2015 9:40am
Hurt, To your point that a prognosticator suggested that the FDA will assign Adcomm spots that will vote as they desire, I have some thoughts on how this may have transpired in Telesta's case; If the FDA desired a NO, wouldn't the majority or all or "practicing urologists" voted NO making the ulimate denial irrevocable and beyond the bounds of appeal? They voted Yes. Those who ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities